Table 1 Patient characteristics for T cell and antibody analyses
Placebo | PEG-IFN-λ | Total | |
|---|---|---|---|
T cell analysis | |||
Total # | 17 | 21 | 38 |
Day 0 | 17 | 21 | 38 |
Day 7 | 16 | 17 | 33 |
Day 90+ | 15 | 19 | 34 |
Sex | |||
Female | 7 | 8 | 15 |
Male | 10 | 13 | 23 |
Median age, years (range) | 41 (22–63) | 47 (21–61) | 45 (21–3) |
IFNL4 genotype | |||
ΔG | 0 | 1 | 1 |
TT/ΔG | 9 | 9 | 18 |
TT | 8 | 11 | 19 |
Antibody analysis Time Points | |||
Day 0 | 12 | 15 | 27 |
Day 7 | 12 | 14 | 26 |
Day 90+ | 11 | 14 | 25 |
Sex | |||
Female | 4 | 8 | 12 |
Male | 8 | 7 | 15 |
Median age, years (range) | 45.5 (22-62) | 42 (21-61) | 43 (21-62) |
IFNL4 genotype | |||
ΔG | 0 | 0 | 0 |
TT/ΔG | 6 | 7 | 13 |
TT | 6 | 8 | 14 |
